Your browser doesn't support javascript.
loading
Subcortical surface morphometry in substance dependence: An ENIGMA addiction working group study.
Chye, Yann; Mackey, Scott; Gutman, Boris A; Ching, Christopher R K; Batalla, Albert; Blaine, Sara; Brooks, Samantha; Caparelli, Elisabeth C; Cousijn, Janna; Dagher, Alain; Foxe, John J; Goudriaan, Anna E; Hester, Robert; Hutchison, Kent; Jahanshad, Neda; Kaag, Anne M; Korucuoglu, Ozlem; Li, Chiang-Shan R; London, Edythe D; Lorenzetti, Valentina; Luijten, Maartje; Martin-Santos, Rocio; Meda, Shashwath A; Momenan, Reza; Morales, Angelica; Orr, Catherine; Paulus, Martin P; Pearlson, Godfrey; Reneman, Liesbeth; Schmaal, Lianne; Sinha, Rajita; Solowij, Nadia; Stein, Dan J; Stein, Elliot A; Tang, Deborah; Uhlmann, Anne; van Holst, Ruth; Veltman, Dick J; Verdejo-Garcia, Antonio; Wiers, Reinout W; Yücel, Murat; Thompson, Paul M; Conrod, Patricia; Garavan, Hugh.
Affiliation
  • Chye Y; Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Victoria, Australia.
  • Mackey S; Departments of Psychiatry, University of Vermont, Burlington, VT, USA.
  • Gutman BA; Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA.
  • Ching CRK; Department of Neurology, Keck School of Medicine, Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, University of Southern California, Los Angeles, CA, USA.
  • Batalla A; Department of Psychiatry, University Medical Centre Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.
  • Blaine S; Department of Psychiatry and Psychology, Hospital Clinic, IDIBAPS, CIBERSAM, Institute of Neuroscience, University of Barcelona, Barcelona, Spain.
  • Brooks S; Departments of Psychiatry and Neuroscience, Yale University School of Medicine, CT, USA.
  • Caparelli EC; Faculty of Health, School of Psychology, Liverpool John Moores University, L3 3AF, Liverpool UK.
  • Cousijn J; Department of Neuroscience, Section of Functional Pharmacology, Uppsala University, 75240, Sweden.
  • Dagher A; Neuroimaging Research Branch, Intramural Research Program, National Institute of Drug Abuse, Baltimore, MD, USA.
  • Foxe JJ; Department of Developmental Psychology, University of Amsterdam, The Netherlands.
  • Goudriaan AE; McConnell Brain Imaging Center, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.
  • Hester R; Department of Neuroscience & The Ernest J. Del Monte Institute for Neuroscience, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA.
  • Hutchison K; Amsterdam UMC, Department of Psychiatry, Amsterdam Institute for Addiction Research, University of Amsterdam, Amsterdam, The Netherlands.
  • Jahanshad N; Department of Research and Quality of Care, Arkin Mental Health Care, Amsterdam, The Netherlands.
  • Kaag AM; Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, Victoria, Australia.
  • Korucuoglu O; Department of Psychology and Neuroscience, University of Colorado Boulder, Boulder, CO, USA.
  • Li CR; Department of Neurology, Keck School of Medicine, Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, University of Southern California, Los Angeles, CA, USA.
  • London ED; Department of Developmental Psychology, University of Amsterdam, The Netherlands.
  • Lorenzetti V; Department of Psychiatry, Washington University School of Medicine, Saint Louis, MO, USA.
  • Luijten M; Departments of Psychiatry and Neuroscience, Yale University School of Medicine, CT, USA.
  • Martin-Santos R; Jane and Terry Semel Institute of Neuroscience and Human Behavior, David Geffen School of Medicine, Universityof California at Los Angeles, Los Angeles, CA, USA.
  • Meda SA; Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, Victoria, Australia.
  • Momenan R; School of Psychology, Faculty of Health Sciences, Australian Catholic University, Melbourne, Victoria, Australia.
  • Morales A; Behavioural Science Institute, Radboud University, Nijmegen, The Netherlands.
  • Orr C; Department of Psychiatry and Psychology, Hospital Clinic, IDIBAPS, CIBERSAM, Institute of Neuroscience, University of Barcelona, Barcelona, Spain.
  • Paulus MP; Olin Neuropsychiatry Research Center, Hartford Hospital/IOL, Hartford, CT, USA.
  • Pearlson G; Clinical NeuroImaging Research Core, Division of Intramural Clinical and BiologicalResearch, National Institute of Alcohol Abuse and Alcoholism, Bethesda, MD, USA.
  • Reneman L; Jane and Terry Semel Institute of Neuroscience and Human Behavior, David Geffen School of Medicine, Universityof California at Los Angeles, Los Angeles, CA, USA.
  • Schmaal L; Departments of Psychiatry, University of Vermont, Burlington, VT, USA.
  • Sinha R; VA San Diego Healthcare System and Department of Psychiatry, University of California San Diego, CA, USA.
  • Solowij N; Laureate Institute for Brain Research, Tulsa, OK, USA.
  • Stein DJ; Departments of Psychiatry and Neuroscience, Yale University School of Medicine, CT, USA.
  • Stein EA; Department of Radiology and Nuclear Medicine, Amsterdam UMC, location AMC, Amsterdam, The Netherlands.
  • Tang D; Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, Australia.
  • Uhlmann A; Centre for Youth Mental Health, The University of Melbourne, Parkville, Australia.
  • van Holst R; Departments of Psychiatry and Neuroscience, Yale University School of Medicine, CT, USA.
  • Veltman DJ; School of Psychology and Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, New South Wales, Australia.
  • Verdejo-Garcia A; The Australian Centre for Cannabinoid Clinical and Research Excellence (ACRE), New Lambton Heights, New South Wales, Australia.
  • Wiers RW; SA MRC Unit on Risk & Resilience in Mental Disorders, Department of Psychiatry and Neuroscience Institute, University of Cape Town, Cape Town, South Africa.
  • Yücel M; Neuroimaging Research Branch, Intramural Research Program, National Institute of Drug Abuse, Baltimore, MD, USA.
  • Thompson PM; McConnell Brain Imaging Center, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.
  • Conrod P; Department of Psychiatry and Mental Health, Faculty of Health Sciences University of Cape Town, South Africa.
  • Garavan H; Department of Psychiatry, University of Amsterdam, Amsterdam, The Netherlands.
Addict Biol ; 25(6): e12830, 2020 11.
Article de En | MEDLINE | ID: mdl-31746534
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Encéphale / Troubles liés à une substance / Neuroimagerie Type d'étude: Prognostic_studies Limites: Adolescent / Adult / Female / Humans / Male Langue: En Journal: Addict Biol Sujet du journal: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Année: 2020 Type de document: Article Pays d'affiliation: Australie Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Encéphale / Troubles liés à une substance / Neuroimagerie Type d'étude: Prognostic_studies Limites: Adolescent / Adult / Female / Humans / Male Langue: En Journal: Addict Biol Sujet du journal: TRANSTORNOS RELACIONADOS COM SUBSTANCIAS Année: 2020 Type de document: Article Pays d'affiliation: Australie Pays de publication: États-Unis d'Amérique